logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Kausik K. Ray

imperial college london

120H-index
842Paper Count
8.7WCitation Count
Published Papers 380
Publication Date
logo
Using gap to goal to guide treatment escalation: lessons from VICTORION-Challenge and beyond
errEuropean Heart Journal
IF35.6
err2026-08-31
err0
errOAAI
errIrene Karungi; Kausik K Ray
errShare
errSave
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
errEuropean Heart Journal
IF35.6
err2026-08-29
err0
errOAAI
errDavid A Wood; Catriona S Jennings; Kornelia Kotseva; Agnieszka Adamska; Iris Erlund; Sandra Ganly; Per-Henrik Groop; Susan Hennessy; Maarten J G Leening; Linda Mellbin; Kausik K Ray; Lars Ryden; Terhi Vihervaara; Victor Aboyans; Ana Abreu; Carlos Aguiar; Karl Andersen; Jolita Badariene; Jan Bruthans; Monika Burzynska; Almudena Castro Conde; Renata Cifkova; Furio Colivicchi; Kairat Davletov; Mirza Dilic; Elena Dimitrova; Maryna Dolzhenko; Vilnis Dzerve; Andrejs Erglis; Zlatko Fras; Baris Gungor; Peter Heuschmann; Piotr Jankowski; Iulia Kulcsar; Nebojsa M Lalic; Seppo Lehto; Dragan Lovic; Aldo P Maggioni; Fabrice MAC Martens; Lampros K Michalis; Davor Milicic; Erkin Mirrakhimov; Greg Murphy; Oner Ozdogan; Jurgita Plisiene; Zeljko Reiner; Stefan Stoerk; Lale Tokgozoglu; Jamol Uzokov; Dusko Vulic; Dirk De Bacquer; John W McEvoy; null
errShare
errSave
Acting on the calcium we already see: Opportunistic coronary artery calcium as a complement to equitable prevention
errAmerican Journal of Preventive Cardiology
IF5.9
err2026-07-01
err0
errOAAI
errLina Yimeng Du; Fatima Rodriguez; Kausik K Ray; Eugene Yang; Daniel Seung Kim
errShare
errSave
Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice
errAmerican Journal of Preventive Cardiology
IF5.9
err2026-05-25
err0
errOAAI
errIrene Karungi; Christophe A.T. Stevens; Julia Brandts; Kausik K Ray
errShare
errSave
Real-world changes in lipid-lowering therapy use and LDL-C goal attainment in high and very high cardiovascular risk patients in the UK: a secondary analysis of the European SANTORINI study 1-year follow-up
errBMJ Open
IF2.3
err2026-04-24
err0
PREAI
errConnolly, Derek; Fuat, Ahmet; McCormack, Terry; Mcnally, Damien; Garstang, Jonathan; Ryan, John; Reed, Amelia; Robinson, Daniel; Catapano, Alberico L.; Ray, Kausik K.
errShare
errSave
Obicetrapib and renal function: A welcome signal, but not yet a kidney story
errAmerican Journal of Preventive Cardiology
IF5.9
err2026-03-27
err0
errOAAI
errFotios Barkas; Kausik K. Ray
errShare
errSave
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: A simulation from the SANTORINI study
errAmerican Journal of Preventive Cardiology
IF5.9
err2026-03-24
err0
errOAAI
errKausik K. Ray; Carlos Aguiar; Marcello Arca; Derek L. Connolly; Mats Eriksson; Jean Ferrières; Ulrich Laufs; Jose M. Mostaza; David Nanchen; Charles Boachie; Ben Lee; Jarkko Soronen; Christian Becker; Ernst Rietzschel; Timo Strandberg; Hermann Toplak; Frank L.J. Visseren; Alberico L. Catapano
errShare
errSave
Obesity, metabolic health status, and adverse outcomes in men and women
errAmerican Journal of Preventive Cardiology
IF5.9
err2026-03-14
err0
errOAAI
errRoshan A Ananda; Bethlehem Solomon; Stephen J Nicholls; Kausik K Ray
errShare
errSave
Low-Density Lipoprotein Cholesterol Lowering and Risk of Major Adverse Cardiovascular Events in Primary Prevention Trials: A Meta-Analysis
errJournal of Clinical Lipidology
IF4.6
err2026-02-13
err0
errOAAI
errDinesh K. Kalra; Kausik K. Ray; Archna Bajaj; Pamela R. Kushner; Meredith L. Wilcox; Mary R. Dicklin; Carol F. Kirkpatrick; Kevin C. Maki
errShare
errSave
Lipid-lowering therapy and LDL cholesterol control among high- and very high-risk patients in Portugal: An analysis of the SANTORINI study
errRevista Portuguesa de Cardiologia
IF1.6
err2026-02-01
err1
errOAAI
errAguiar, Carlos; Aguiar, Patricio; Duarte, Joao Sequeira; Gil, Victor; Mimoso, Jorge; Monteiro, Pedro; Pinto, Fausto J.; Pinto, Fernando; Raposo, Joao; Von Hafe, Pedro; Ruivo, Jorge A.; Teixeira, Carla; Catapano, Alberico L.; Ray, Kausik K.
errShare
errSave
Corneal arcus and Achilles tendon thickness reflect circulating lipoprotein(a) levels in familial hypercholesterolemia: Implication for predicting future cardiovascular events
errJournal of Clinical Lipidology
IF4.6
err2025-11-20
err0
PREAI
errKota Murai; Yu Kataoka; Kausik K. Ray; Sayaka Funabashi; Mika Hori; Masatsune Ogura; Takahito Doi; Hisashi Makino; Teruo Noguchi; Mariko Harada-Shiba
errShare
errSave
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
errEUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
IF7.5
err2025-11-01
err0
errOAAI
errSki, Chantal F.; Jennings, Catriona S.; De Bacquer, Dirk; Kotseva, Kornelia; Mcevoy, John William; De Backer, Guy; Erlund, Iris; Ganly, Sandra; Vihervaara, Terhi; Lip, Gregory Yoke Hong; Ray, Kausik K.; Ryden, Lars; Adamska, Agnieszka; Abreu, Ana; Almahmeed, Wael; Ambari, Ade Meidian; Ge, Junbo; Hasan-Ali, Hosam; Huo, Yong; Jankowski, Piotr; Jimenez, Rodney M.; Li, Yong; Zuhdi, Ahmad Syadi Mahmood; Makubi, Abel; Mbakwem, Amam Chinyere; Mbau, Lilian; Estrada, Jose Luis Navarro; Ogah, Okechukwu Samuel; Ogola, Elijah Nyainda; Quintero-Baiz, Adalberto; Sani, Mahmoud Umar; Liprandi, Maria Ines Sosa; Tan, Jack Wei Chieh; Triana, Miguel Alberto Urina; Yeo, Tee Joo; Wood, David A.; Thompson, David R.
errShare
errSave
Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort
errNutrition, Metabolism and Cardiovascular Diseases
IF0
err2025-10-14
err0
PREAI
errMarcello Arca; Paolo Calabrò; Anna Solini; Angela Pirillo; Rosanna Gambacurta; Kausik K. Ray; Alberico L. Catapano
errShare
errSave
Lipid-lowering therapy treatment regimens in high- and very high-risk patients for the prevention of cardiovascular events: results from the Irish cohort of the multinational, observational SANTORINI study
errIRISH JOURNAL OF MEDICAL SCIENCE
IF1.6
err2025-10-01
err0
PREAI
errRai, Himanshu; Coughlan, John Joseph; O'callaghan, Daniel; Sheahan, Richard; Murphy, Ross; Burke, David; Mcfadden, Eugene; Nolan, Dermot; Colleran, Roisin; Hazeez-Agbaje, Abiola; Ray, Kausik K.; Catapano, Alberico L.; Byrne, Robert A.
errShare
errSave
Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK
errEUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
IF7.5
err2025-10-01
err1
errOAAI
errRay, Kausik K.; Reuter, Simon Bertram; Dalbeler, Aysegul; Faurby, Mads D.; Letnar, Gasper; Mathisen, Jimmi; Nanna, Michael G.; Ng, Fu Siong; Pearson-Stuttard, Jonathan; Sattar, Naveed; Thompson, Andrew; Navar, Ann Marie
errShare
errSave
Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study
errREVISTA CLINICA ESPANOLA
IF1.7
err2025-09-01
err1
errOAAI
errMostaza, J. M.; Lahoz, C.; Castro, M. Garcia de Yebenes; Campal, J. M. Rubio; Velasquez, E.; Gutierrez, A. Ibarra; Diaz, J. F.; Plana, N.; Rodriguez-Manero, M.; Garcia-Diaz, J. D. de Dios; Deben, F. Martinez; de Paz, I. Pavon; Catapano, A. L.; Moya, G. Diaz; Ray, K. K.
errShare
errSave
Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid Clinical Insights From CLEAR Outcomes
errJACC-ADVANCES
IF0
err2025-09-01
err0
errOAAI
errRay, Kausik K.; Nicholls, Stephen J.; Lincoff, A. Michael; Li, Na; Powell, Heather A.; Herout, Peter M.; Bloedon, LeAnne; Nissen, Steven E.
errShare
errSave
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients
errJACC
IF0
err2025-09-01
err0
errOAAI
errStephen J. Nicholls; Adam J. Nelson; Kausik K. Ray; Christie M. Ballantyne; Marc Ditmarsch; Douglas Kling; Andrew Hsieh; Michael Szarek; John J. Kastelein; Michael H. Davidson
errShare
errSave
2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidemias - Advancing evidence-based care through innovation
errAtherosclerosis
IF5.7
err2025-08-29
err0
PREAI
errFlorian Kronenberg; Jan Borén; Kausik K. Ray
errShare
errSave
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events
errJACC
IF0
err2025-08-27
err0
PREAI
errKausik K. Ray; Michael Szarek; Deepak L. Bhatt; Vera A. Bittner; Sergio Fazio; Shaun G. Goodman; Robert A. Harrington; J. Wouter Jukema; Harvey D. White; Ph. Gabriel Steg; Gregory G. Schwartz
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
G
George Davey Smith
H-index: 276 · Papers: 4.3K
N
Nicholas J. Wareham
H-index: 233 · Papers: 2.2K
J
John J.V. McMurray
H-index: 231 · Papers: 2.7K
P
Peter Libby
H-index: 227 · Papers: 1.3K
P
Paul M. Ridker
H-index: 226 · Papers: 1.4K
View more